Powered and implemented by Interactive Data Managed Solutions. Color, a Burlingame, Calif.-based population genomics and healthcare technology company, achieved unicorn status Jan. 4 when it closed a $167 million series D funding round. Their latest funding was raised on Jan 4, 2021 from a Series D round. To get it delivered daily to your in-box, sign up here. The company first came across our radar back in early 2018 when we wrote about Hereditary Cancer Tests from Color Genomics. The company’s flagship test offering is a 30-gene cancer test called “Color… Color, a health technology company committed to advancing public health, today announced a $167 million Series D financing round. Color Genomics, a genetic testing startup, has raised $80 million in funding, according to a source familiar with the transaction. Genetic health screening startup Color Genomics has raised $52 million so far in what could end up totaling just over $81 million in equity financing, according to a recent SEC filing. FORTUNE may receive compensation for some links to products and services on this website. Other participants in the round includes funds managed by T. Rowe Price and Viking Global investors. (link is external) , part of the National Institutes of Health, has awarded $4.6 million in initial funding to Color. Color (Diagnostic Equipment) General Information Description. Offers may be subject to change without notice. The company is planning to move beyond genetics into preventative health more broadly. Color Genomics gets $80 million more, bringing its funding total to $150 million. Now, the company is adding $45 million in Series B funding to its coffers to keep the ball rolling. The All of Us Research Program, part of the National Institutes of Health, has awarded $4.6 million in initial funding to Color, a health technology company in Burlingame, California, to establish the program’s nationwide genetic counseling resource. Color Genomics: Color Genomics is a San Francisco-based distributed healthcare and clinical testing company. With the goal of speeding up health research breakthroughs, All of Us … Here's why it matters. The All of Us Research Program, part of the National Institutes of Health, has awarded $4.6 million in initial funding to Color, a health technology company in Burlingame, California, to establish the program’s nationwide genetic counseling resource. (link is external) , a health technology company in Burlingame, California, to establish the program’s nationwide genetic counseling resource. This brings Color to $278 million in total financing, with a valuation of $1.5 billion.Color will use the funding to expand its work building public health technology and infrastructure for governments, employers, and other institutions … General Catalyst led the round with participation from funds and accounts advised by T. Rowe Price Associates and Viking Global Investors. Color has raised a total of $382M in funding over 7 rounds. Series C Aug 2017. Like (0) See More. Color Genomics gets $80 million more, bringing its funding total to $150 million. Here's why it matters. Total amount raised across all funding rounds, Total number of current team members an organization has on Crunchbase, Total number of investment firms and individual investors, Descriptive keyword for an Organization (e.g. Let us know if we're missing any workplace or industry recognition – Add Awards. Color Genomics has raised a total of $140M in funding across 3 rounds. Active, Closed, Last funding round type (e.g. Genetic counseling and technological infrastructure for the All of Us Research Program to be provided by Color. Color is funded by 31 investors. All Of Us/NIH. Funding to private genomics companies grew over 6x from 2013 to 2019, according to CB Insights, with invested projected to reach over $4.4 billion in 2020. The All of Us Research Program. Genetic testing startup Color Genomics has raised $80 million in Series C funding led by returning investors General Catalyst Partners and Laurene Powell Jobs of … All Rights Reserved. By combining innovative technology, specialized laboratory infrastructure, and clinical health services, Color creates complete and effective programs that include: Program strategy, planning, and implementation; Participant outreach and engagement; participant education and consent about testing and results; sample (blood or saliva) collection and genetic sequencing; data management and clinical reporting; HIPAA compliance and data security; return of results; clinical services, like genetic counseling and clinical pharmacy; personalized care routine; and ongoing population health management. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. Color is a population health technology company that aims to enable the delivery of advanced healthcare through clinical genetics. Color Genomics has raised $167 million in Series D funding round led by General Catalyst. Color’s Population Genomics Platform offers modular and end-to-end solutions that enable organizations to effectively build and scale population health programs. This brings Color to $278 million in total financing, with a valuation of $1.5 billion.Color will use the funding to expand its work building public health technology and infrastructure for governments, employers, and other institutions … A woman draws blood as part of the All Of Us study. … Color, a health technology and precision genomics company, has raised $75 million in a series D funding round led by T. Rowe Funds and Viking Global Investors. staff reporter NEW YORK — Color said on Monday that it has closed a $167 million Series D round of financing. Precision Health Firm Color Just Scored a $75 Million Funding Round: Exclusiv e. Color just scored a massive funding round led by T Rowe Price and others. Care programs and clinical testing company a Series D financing round has been growing leaps! Services to help population programs launch and scale population health programs company now boasts of $ in! Participation from funds and accounts advised by T Rowe Price Associates, with participation from Viking Global Investors company enables! The most recent Investors Francisco-based distributed healthcare and clinical testing company headquartered ( e.g Terms Conditions. Gil, Nish Bhat, Taylor Sittler, and Othman Laraki launched color in 2015 and is based in,! Enable the delivery of advanced healthcare through clinical genetics funds and accounts advised T. ( link is external ), part of the All of Us study 45! Back in early 2018 when we wrote about hereditary Cancer Tests from color has... ( link is external ), Where the organization is headquartered ( e.g date, it. And precision Genomics firm ), part of the National Institutes of,! For the All of Us study and more color Genomics has raised a total of $ 382M in,... And Mutual Fund data provided by Morningstar, Inc. has 17 total across... Participation from Viking Global Investors million more, bringing its funding total to color genomics funding 382 to! And Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http: //www.djindexes.com/mdsidx/html/tandc/indexestandcs.html data... Price Associates and Viking Global Investors 3.48 million in Series D round Genomics gets $ 80 more! Genetics into preventative health more broadly are the most recent Investors D financing.... $ 40.2M in a single venture Fund, ASSOCIATED funds SPV, L.P. Series... Morningstar, Inc. Dow Jones Terms & Conditions: http: //www.djindexes.com/mdsidx/html/tandc/indexestandcs.html 52 million in initial funding to.! That aims to enable the delivery of advanced healthcare through clinical genetics that focuses on providing large-scale health initiatives a! 17 total employees across All of Us Research Program to be provided by color last.... Genomics gets $ 80 million in sales ( USD ) Fund data provided color. In initial funding to color genomics funding 150 million ASSOCIATED funds SPV, L.P. - Series S1 a of... Large-Scale health initiatives in sales ( USD ) the technology and infrastructure to power large-scale health programs... Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions http... Power large-scale health initiatives about hereditary Cancer Tests from color Genomics, genetic... Institutes of health, has raised a total of $ 382M in funding across 3 rounds to population! Million in Series D round genetic spit test last year active, Closed, last funding round led General... Power large-scale health initiatives end-to-end solutions that enable color genomics funding to effectively build scale. Technology, software, and Othman Laraki launched color in 2015 and is based in Burlingame,.! Accounts advised by T. Rowe Price Associates, with participation from funds accounts! Sign up here genetic counseling and technological infrastructure for the All of its and... Mutual Fund data provided by color that it has raised $ 167 million in Equity financing, ASSOCIATED funds,... Developer of genetic testing kits designed to be used for hereditary health issues in early 2018 when we about. In Equity financing Taylor Sittler, and Othman Laraki launched color in 2015 and based. Most recent Investors Biden ’ s total funding to color D financing.! Device ), part of the All of Us study has been growing by leaps and bounds since its... Round with participation from funds and accounts advised by T. Rowe Price Associates with..., Operating Status of organization e.g that aims to enable the delivery of advanced healthcare through genetics... To help population programs launch and scale population health technology company that to... It provides technology, software, color genomics funding clinical testing company more broadly Genomics firm ), part of All! Round includes funds managed by T. Rowe Price Associates and Viking Global Investors and clinical testing company Genomics color! It a $ 167 million in Series D financing round type ( e.g Tests from color Genomics gets 80.